Showing 161 - 180 results of 21,158 for search '(( ct cases increased ) OR ((( a greater decrease ) OR ( ((a large) OR (i large)) decrease ))))', query time: 1.34s Refine Results
  1. 161

    Table3_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…DLBCL cohort analysis found that RAB39B expression was related to 14 m6A modifier genes, including YTHDC1, YTHDC2, YTHDF1, YTHDF2, YTHDF3, RBMX, ZC3H13, METTL14, METTL3, RBM15, RBM15B, VIRMA, FTO, and ALKBH5. …”
  2. 162

    Table6_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…DLBCL cohort analysis found that RAB39B expression was related to 14 m6A modifier genes, including YTHDC1, YTHDC2, YTHDF1, YTHDF2, YTHDF3, RBMX, ZC3H13, METTL14, METTL3, RBM15, RBM15B, VIRMA, FTO, and ALKBH5. …”
  3. 163

    Table2_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…DLBCL cohort analysis found that RAB39B expression was related to 14 m6A modifier genes, including YTHDC1, YTHDC2, YTHDF1, YTHDF2, YTHDF3, RBMX, ZC3H13, METTL14, METTL3, RBM15, RBM15B, VIRMA, FTO, and ALKBH5. …”
  4. 164

    Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…DLBCL cohort analysis found that RAB39B expression was related to 14 m6A modifier genes, including YTHDC1, YTHDC2, YTHDF1, YTHDF2, YTHDF3, RBMX, ZC3H13, METTL14, METTL3, RBM15, RBM15B, VIRMA, FTO, and ALKBH5. …”
  5. 165
  6. 166
  7. 167
  8. 168
  9. 169
  10. 170

    <b>Warming alters plankton body-size distributions in a large field experiment</b> by Dania Albini (20288463)

    Published 2024
    “…We found a nonlinear decrease in the overall mean body size of zooplankton with warming, with a 57% reduction at +8°C. …”
  11. 171

    Supplementary Material for: Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease by Fabbrocini G. (7463126)

    Published 2021
    “…<b><i>Objective:</i></b> To evaluate how the burden of HS disease impacts on patient well-being and working activities in a large Italian population over a period of 9 months. …”
  12. 172
  13. 173

    Fig 1 - by Denise Wajnsztajn (3366902)

    Published 2022
    Subjects:
  14. 174

    UV Reconfigurable Shape Memory Polyurethane with a High Recovery Ratio under Large Deformation by Jing Hu (41899)

    Published 2021
    “…Thus, the spontaneous shape change from two-dimensional (2D) to 3D was realized, in combination with melting transition, and the dedimerization of anthracene ensured the recyclability of polyurethane at <i>T</i> = 150 °C. This simple and facile strategy could be used to fabricate the recyclable and photoplasticity shape memory TPU with a high shape-fixing/recovery ratio at large deformation, and it would have a wider range of potential application in stents.…”
  15. 175

    DataSheet1_Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5−/− mice, decreases plasma cholesterol and epididymal fat deposition.PDF by Sunil Veeravalli (5074115)

    Published 2022
    “…<p>We previously showed that Fmo5<sup>−/−</sup> mice exhibit a lean phenotype and slower metabolic ageing. Their characteristics include lower plasma glucose and cholesterol, greater glucose tolerance and insulin sensitivity, and a reduction in age-related weight gain and whole-body fat deposition. …”
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180